Highest-materiality recent filing
HealthLynked issues $5.7M secured convertible note to CEO's trust at 12%, convertible at $4.25
Principal $5,715,811.98 to Mary S. Dent Gifting Trust (controlled by CEO Dr. Michael Dent).
HealthLynked appoints COO and adds two directors; targets Nasdaq uplist in 2026
Duncan McGillivray appointed COO effective Dec 8, 2025; base salary $120K/yr, rising to $150K on Nasdaq uplist.
HealthLynked effects 1-for-100 reverse stock split; shares reduced to ~2.85M
Reverse stock split at 1-for-100 ratio effective September 4, 2025; CUSIP changed to 42228P 300.
HealthLynked issues $420K convertible note to CEO's trust; extends $1.22M in notes
Issued $420,000 convertible promissory note to Mary S. Dent Gifting Trust, controlled by CEO Dr. Michael Dent, to replace undocumented advances from Sep-Nov 2024.
CEO Michael Dent invested over $3M personally over last 16 months, expressing confidence in company's vision.
HealthLynked appoints Jeremy Daniel as part-time CFO; David Rosal resigns
Jeremy Daniel appointed CFO effective Jan 15, 2025; replaces David Rosal who resigned without disagreement.
HealthLynked issues $900K convertible notes at 12% with warrant to CEO's trust
Aggregate principal $900,000, net proceeds $855,000 after 5% OID; issued in 10 tranches from July to Sept 2024.
HealthLynked appoints William Crupi as COO effective June 25, 2024
William Crupi, 35, previously Operations Manager since April 2023, named COO.
HealthLynked CEO Dr. Michael Dent provides $1M convertible note financing via trust
Issued $1M senior secured convertible note to Mary S. Dent Gifting Trust (CEO-controlled) on June 3, 2024.
HealthLynked appoints David Rosal as CFO effective March 11, 2024
David Rosal, 61, appointed CFO effective immediately on March 11, 2024.
HealthLynked CFO George O'Leary resigns effective April 4, 2024; stays on board
George O'Leary resigned as CFO, effective April 4, 2024; not due to any disagreement.
HealthLynked issues shareholder letter; details unavailable in filing
Company issued a shareholder letter on December 26, 2023, furnished as Exhibit 99.1.
HealthLynked retires $550,000 promissory note with Yorkville in full
Note issued July 19, 2022, amended Nov 15, 2022; final payment made March 17, 2023.
HealthLynked appoints Paul J. Hobaica, MD to board; Robert Mino resigns
Independent director Robert Mino resigned March 13, 2023; not due to any disagreement.
HealthLynked sells ACO Health Partners to PBACO for up to $3M cash plus up to $7M in IPO shares
$750K cash at signing; up to $2.25M incremental cash based on physician participation by July 31, 2023.
HealthLynked amends $550K promissory note, extends maturity to March 2023
Original $550K note matured Jan 19, 2023; maturity extended to March 15, 2023.
HealthLynked CFO O'Leary gets new offer letter with salary $259K, stock grants, options at $0.06
Base salary $259,000/year effective July 1, 2022; annual bonus 25% of salary tied to financial metrics.
HealthLynked issues $550K promissory note to Yorkville with 5% OID, 5-month maturity
Note issued July 19, 2022 to YA II PN, Ltd.; net proceeds ~$522,500 after 5% OID.
HealthLynked enters equity line for up to 30M shares; issues 895K commitment shares to Yorkville
Standby Equity Purchase Agreement with YA II PN allows sale of up to 30M shares at 96% of Market Price.
HealthLynked acquires Aesthetic Enhancements for $425K; Q1 revenue $1.6M, net loss down 85%
Acquired Aesthetic Enhancements LLC for $425K ($325K cash + $100K stock) adding 4,750 patients and $500K revenue in 2021.
HealthLynked raises $2M in registered direct offering at $0.54/share
3,703,704 shares sold at $0.54 each for gross proceeds of $2M; expected close Aug 31, 2021.
Effective January 15, 2025, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed Jeremy Daniel, age 48, as its part-time Chief Financial Officer, effective immediately.
Effective January 15, 2025, David Rosal tendered his resignation as Chief Financial Officer of the Company.
On June 25, 2024, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed William Crupi, age 35, as its Chief Operating Officer, effective immediately.
appointed David Rosal, age 61, as its Chief Financial Officer, effective immediately.
On January 5, 2024, George O'Leary tendered his resignation as Chief Financial Officer of HealthLynked Corp., a Nevada corporation (the “ Company ”) effective April 4, 2024.
On March 13, 2023, the Board appointed Paul J. Hobaica, M.D. as a director of the Company, effective immediately, to fill the vacancy created by Robert Mino’s resignation.
On March 13, 2023, the Board of Directors (the “ Board ”) of HealthLynked Corp., a Nevada corporation (the “ Company ”) accepted independent director Robert Mino’s resignation, effective immediately.
Max materiality 0.65 · Median 0.55 · Most common event debt